The corporate regulator has won its case against Bit Trade, the Australian provider of the Kraken crypto exchange, after a judge rejected the company’s argument that its product was not a credit facility.Â
Gaming giant Aristocrat has defeated a challenge by Light & Wonder to discovery orders it won for a possible lawsuit alleging two former employees who jumped ship to its rival misused confidential information about its popular Lightning Link and Dragon Link games.
Online auction site Grays has been ordered to pay $10 million in penalties after it admitted to making misleading statements in the descriptions of at least 750 cars listed for sale on its website.Â
The Australian provider of the Kraken crypto exchange has told a court that its margin trading product is not a credit facility, rejecting the corporate regulatorâs âoverly broadâ definition of the word âcreditâ.Â
A judge has upheld Neurim Pharmaceuticalâs claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company’s failure to comply with an earlier ruling.
A judge has rejected Aristocratâs bid for orders requiring competitor Light & Wonder to hand over documents to be placed âin an envelopeâ for speedy production should its appeal of a decision ordering that it produce the documents to Aristocrat for possible trade secrets suit fail.
South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.
Game maker Light & Wonder is fighting orders requiring it to hand over information to Aristocrat Gaming for a possible suit alleging it and two former employees who jumped ship misused confidential information about Aristocrat’s popular Lightning Link and Dragon Link games.
Casino gaming giant Aristocrat may sue competitor Light & Wonder and two former employees who jumped ship for allegedly misusing confidential information about its popular Lightning Link and Dragon Link games to develop a competing product.
After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceuticalâs patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.